๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kuangli Bio-Tech Holdings Co., Ltd. (TPE:6431)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
14.25
-1.05 (-6.86%)
Nov 20, 2026, 1:30 PM CST

Kuangli Bio-Tech Holdings Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
430.76377.03381.3293.37342.16332.63
Revenue Growth
11.20%-1.12%29.97%-14.26%2.86%282.47%
Gross Profit
137.8270.4168.3266.368.6990.94
Operating Income
-148.02-157.48-145.06-113.65-89.03-7.39
Net Income
-174.09-192.98-172.79-104.16-68.7225.84
Earnings Per Share
-1.79-2.07-2.52-1.82-1.220.51
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Health Management Department
35.0441.930.0916.36--
Biotechnology Segment
341.26335.13351.22277.02342.16332.63
Total
363.27377.03381.3293.37342.16332.63

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
90.86208.9341.5972.41141.89162.17
Total Debt
462.88487.33336.82421.52349.75348.33
Net Cash (Debt)
-372.02-278.4-295.24-349.11-207.86-186.15
Net Cash Growth
------
Net Cash Per Share
-3.82-2.99-4.30-6.10-3.69-3.67

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.25-145.33-65.23-62.36-9.2421.69
Capital Expenditures
-35.62-9.32-12.44-25.21-34.22-40.36
Free Cash Flow
-42.86-154.65-77.68-87.58-43.46-18.67
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
32.00%18.68%17.92%22.60%20.08%27.34%
Operating Margin
-34.36%-41.77%-38.04%-38.74%-26.02%-2.22%
Pretax Margin
-38.64%-51.20%-47.83%-42.16%-24.70%17.86%
Profit Margin
-40.41%-51.18%-45.32%-35.50%-20.09%7.77%
FCF Margin
-9.95%-41.02%-20.37%-29.85%-12.70%-5.61%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----53.87
Forward PE
-12.6512.6512.6512.6512.65
PS Ratio
3.226.952.753.433.404.18